A carregar...
Balancing and communicating the risks and benefits of biologics in pediatric inflammatory bowel disease
Anti-tumor necrosis factor agents are now considered to be a vital component of the treatment algorithm for pediatric inflammatory bowel disease. Despite the clear benefit of these agents and the re-alignment of treatment goals to achieve early mucosal healing, the decision to initiate therapy is of...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3938311/ https://ncbi.nlm.nih.gov/pubmed/23867874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MIB.0b013e31829aad16 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|